Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 27, 2015 10:38 AM ET

Pharmaceuticals

Company Overview of Nivalis Therapeutics, Inc.

Key Executives for Nivalis Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Jon Congleton 11 RelationshipsChief Executive Officer, President and Director--
R. Michael Carruthers 14 RelationshipsChief Financial Officer56
Janice Troha No RelationshipsExecutive Vice President of Product Development & Regulatory--
Sherif Gabriel Ph.D.No RelationshipsVice President of Research--

Nivalis Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Howard P. Furst M.D. 17 RelationshipsDeerfield Management Company, L.P.47
Jon Congleton 11 RelationshipsNivalis Therapeutics, Inc.--
Joseph Loscalzo M.D., Ph.D. 106 RelationshipsNitroMed, Inc.62
Arnold Snider 95 RelationshipsNivalis Therapeutics, Inc.--
Charles H. Scoggin M.D. 11 RelationshipsNivalis Therapeutics, Inc.69
View All Board Members

Nivalis Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D., Ph.D.Joseph Loscalzo106 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
436.8K
Bonus
543.8K
Total Short Term Compensation
628.0K
Total Value of Options
30.2M
Compensation as of Fiscal Year
Nivalis Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Anders Nyrén to Leave His Assignment as Member of SCA Board of Directors as of April 30, 2015
April 27, 2015 5:58 AM ET
The Clorox Company Announces Retirement of Daniel Boggan as Directors, Effective May 13, 2015
April 24, 2015 9:00 PM ET
Worldwise Promotes Jeff Leh to Vice President of Sales
April 22, 2015 10:15 AM ET
Oil-Dri Corp. of America Announces Management Changes
April 17, 2015 8:15 PM ET
P&G Announces Executive Changes
April 14, 2015 1:58 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nivalis Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.